A-SEEDS - Crunchbase Company Profile & Funding

Q: Where is A-SEEDS's headquarters?

A-SEEDS is located in Matsumoto, Nagano, Japan.

Q: Who invested in A-SEEDS?

A-SEEDS has 10 investors including SMBC Venture Capital And Osaka University Venture Capital.

Q: When was the last funding round for A-SEEDS?

A-SEEDS closed its last funding round on obfuscated from a Series A round.

Overview

A-SEEDS

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About A-SEEDS

CB Rank

76264

A-SEEDS is a biotech company that researches and develops regenerative medicines, especially for cancer patients.

Founded

obfuscation

Private

Series A

Matsumoto, Nagano, Japan

11-50

www.a-seeds.co.jp/

Biotechnology

Genetics

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Grant

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Shigeki Yagyu: CEO
Kiyohito Tani: COO

Details

Legal Name

A-Seeds Co., Ltd.

Operating Status

Active

Company Type

For Profit

Founders

Yozo Nakazawa

About the Company

A-SEEDS is a biotech company sprouted from Shinshu University, is dedicated to pioneering advanced treatments for life-threatening cancers. Harnessing the potential of non-viral genetic engineering, our cutting-edge immune cell therapy opens up new horizons of hope for patients seeking effective and transformative solutions.

Phone Number

+81 026-331-5882

Contact Email

info@a-seeds.co.jp

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

Non-viral Gene-Modified CAR-T Cell Therapy

A cancer treatment using T lymphocytes genetically modified without viral vectors to express chimeric antigen receptors, enhancing their ability to attack cancer cells.

AP8901 CAR-T Cell Product

A CAR-T cell therapy product targeting two cancer antigens, EPHB4 and EPHA2, designed to attack diverse solid tumor cells simultaneously.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - A-SEEDS	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - A-SEEDS	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - A-SEEDS	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - A-SEEDS	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - A-SEEDS	8	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - A-SEEDS	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - A-SEEDS	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - A-SEEDS	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - A-SEEDS	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - A-SEEDS	8	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
SMBC Venture Capital	—	Series A - A-SEEDS	—
SMBC Venture Capital	—	Series A - A-SEEDS	—
SMBC Venture Capital	—	Series A - A-SEEDS	—
SMBC Venture Capital	—	Series A - A-SEEDS	—
SMBC Venture Capital	—	Series A - A-SEEDS	—